Cogent Biosciences (COGT) Free Cash Flow: 2017-2024
Historic Free Cash Flow for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to -$208.4 million.
- Cogent Biosciences' Free Cash Flow fell 126.46% to -$21.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$60.4 million, marking a year-over-year decrease of 68.37%. This contributed to the annual value of -$208.4 million for FY2024, which is 33.21% down from last year.
- As of FY2024, Cogent Biosciences' Free Cash Flow stood at -$208.4 million, which was down 33.21% from -$156.4 million recorded in FY2023.
- Over the past 5 years, Cogent Biosciences' Free Cash Flow peaked at -$35.9 million during FY2020, and registered a low of -$208.4 million during FY2024.
- Its 3-year average for Free Cash Flow is -$163.4 million, with a median of -$156.4 million in 2023.
- Its Free Cash Flow has fluctuated over the past 5 years, first grew by 13.71% in 2020, then plummeted by 107.50% in 2022.
- Cogent Biosciences' Free Cash Flow (Yearly) stood at -$35.9 million in 2020, then plummeted by 68.71% to -$60.5 million in 2021, then plummeted by 107.50% to -$125.5 million in 2022, then dropped by 24.64% to -$156.4 million in 2023, then plummeted by 33.21% to -$208.4 million in 2024.